Transfer of the nerve growth factor gene into cell lines and cultured neurons using a defective herpes simplex virus vector. Transfer of the NGF gene into cells by a HSV-1 vector.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Brain Research. Molecular Brain Research

• Publication date

  1994-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0169-328X(94)90146-5PMID 7968372
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding

  1993cited by this paper
• Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia.

  1992cited by this paper
• Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of MAP kinases.

  1992cited by this paper
• ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK.

  1992cited by this paper
• Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity.

  1992cited by this paper
• trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor.

  1991cited by this paper
• Molecular analysis of neuronal physiology by gene transfer into neurons with herpes simplex virus vectors.

  1991cited by this paper
• Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF

  1991cited by this paper
• High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor

  1991cited by this paper
• Trkl3 mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor

  1991cited by this paper
• Cytokine regulation of substance P expression in sympathetic neurons.

  1991cited by this paper
• The trk proto-oncogene product: a signal transducing receptor for nerve growth factor.

  1991cited by this paper
• The trk proto-oncogene rescues NGF responsiveness in mutant NGF-nonresponsive PC12 cell lines.

  1991cited by this paper
• Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB.

  1991cited by this paper
• The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor.

  1991cited by this paper
• trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3.

  1991cited by this paper
• Expression of a functional foreign gene in adult mammalian brain following in Vivo transfer via a herpes simplex virus type 1 defective viral vector.

  1991cited by this paper
• The trk proto-oncogene encodes a receptor for nerve growth factor.

  1991cited by this paper
• Primary structure and biological activity of a novel human neurotrophic factor.

  1990cited by this paper
• Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase.

  1990cited by this paper
• Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family

  1990cited by this paper
• Trophic factors and neuronal survival.

  1989cited by this paper
• Molecular cloning and expression of brain-derived neurotrophic factor

  1989cited by this paper
• A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons.

  1988cited by this paper
• Expression of preproenkephalin mRNA by cultured astrocytes and neurons.

  1988cited by this paper
• Processing and secretion of nerve growth factor: expression in mammalian cells with a vaccinia virus vector

  1988cited by this paper
• Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression.

  1988cited by this paper
• Comparison of nerve growth factor's effects on development of septum, striatum, and nucleus basalis cholinergic neurons in vitro

  1988cited by this paper
• Brain-derived neurotrophic factor prevents neuronal death in vivo

  1988cited by this paper
• PC12 pheochromocytoma cells: culture, nerve growth factor treatment, and experimental exploitation.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• The physiological function of nerve growth factor in the central nervous system: comparison with the periphery.

  1987cited by this paper
• Nerve growth factor treatment after brain injury prevents neuronal death.

  1987cited by this paper
• Retrograde cell changes in medial septum and diagonal band following fimbria-fornix transection: quantitative temporal analysis.

  1986cited by this paper
• Differential regulation of peptide and catecholamine characters in cultured sympathetic neurons.

  1985cited by this paper
• Nerve growth factor in sympathetic ganglia and corresponding target organs of the rat: correlation with density of sympathetic innervation.

  1983cited by this paper
• The Human Growth Hormone Gene Family: Nucleotide Sequences Show Recent Divergence and Predict a New Polypeptide Hormone

  1981cited by this paper
• Similarities in development of substance P and somatostatin in peripheral sensory neurons: effects of capsaicin and nerve growth factor.

  1981cited by this paper
• Physiology of nerve growth factor.

  1980cited by this paper
• The effects of nerve growth factor (NGF) and antiserum to NGF on the development of embryonic sympathetic neurons in vivo.

  1980cited by this paper
• Nerve growth factor stimulates the development of substance P in sensory ganglia.

  1980cited by this paper
• The role of axonal transport in the regulation of enzyme activity in sympathetic ganglia of adult rats.

  1979cited by this paper
• The effect of taget organ removal on the development of sympathetic neurons.

  1976cited by this paper
• Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities.

  1969cited by this paper

• Neurotrophin mimetics and tropomyosin kinase receptors: a futuristic pharmacological tool for Parkinson’s

  2023cites this paper
• Application to Gene Therapy and Vaccination

  2017cites this paper
• chronic lymphocytic leukemia based immunotherapy for - Development of herpes simplex virus-1 amplicon

  2013cites this paper
• Gene therapy for the peripheral nervous system: a strategy to repair the injured nerve?

  2011cites this paper
• COVALENT IMMOBILIZATION OF L1 NEURAL CELL ADHESION MOLECULE TO ACRYLATED TETRONIC® HYDROGELS FOR NEURAL REGENERATION

  2009cites this paper
• Gene Therapy and Vaccination

  2008cites this paper
• Infectivity of herpes simplex virus type-1 (HSV-1) amplicon vectors in dendritic cells is determined by the helper virus strain used for packaging.

  2007cites this paper
• Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival.

  2007cites this paper
• Gene transfer to the nerve system using HSV-1-derived amplicon vectors.

  2006cites this paper
• Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia

  2005cites this paper
• Advances in gene transfer and pharmacological regulation of protein aggregation in the treatment of Alzheimer’s and parkinson’s diseases

  2005cites this paper
• Brain Targeting Of Nerve Growth Factor Using Poly(Butylcyanoacrylate) Nanoparticles

  2004cites this paper
• Immune responses to replication-defective HSV-1 type vectors within the CNS: implications for gene therapy

  2003cites this paper
• Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS.

  2003cites this paper
• CNS diseases amenable to gene therapy.

  2003cites this paper
• Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity.

  2002cites this paper
• Somatic mosaic approaches and the aging brain.

  2002cites this paper
• Pharmacological, Cell, and Gene Therapy Strategies to Promote Spinal Cord Regeneration

  2002cites this paper
• Reporter gene transfer induces apoptosis in primary cortical neurons.

  2002cites this paper
• HSV Amplicon Vectors in Neuronal Apoptosis Studies

  2002cites this paper
• A novel approach to cancer therapy using an oncolytic herpes virus to package amplicons containing cytokine genes.

  2001cites this paper
• Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia.

  2001cites this paper
• Combination Vascular Delivery of Herpes Simplex Oncolytic Viruses and Amplicon Mediated Cytokine Gene Transfer Is Effective Therapy for Experimental Liver Cancer

  2001cites this paper
• Gene therapeutic approaches to the treatment of Parkinson's disease

  2001cites this paper
• HSV vector-mediated gene delivery to the central nervous system.

  2001cites this paper
• Enhanced Learning in Mice Parallels Vector-Mediated Nerve Growth Factor Expression in Hippocampus

  2000cites this paper
• A multi-mutant herpes simplex virus vector has minimal cytotoxic effects on the distribution of filamentous actin, alpha-actinin 2 and a glutamate receptor in differentiated PC12 cells.

  2000cites this paper
• Labeling and Identifying Grafted Cells

  2000cites this paper
• The role of HSV amplicon vectors in cancer gene therapy

  2000cites this paper
• Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases

  1999cites this paper
• BCL-2 transduction, using a herpes simplex virus amplicon, protects hippocampal neurons from transient global ischemia.

  1999cites this paper
• A spermine-deoxycholic acid conjugate based lipid as a transfecting agent.

  1999cites this paper
• Herpes Simplex Virus Type 1 Vector-Mediated Expression of Nerve Growth Factor Protects Dorsal Root Ganglion Neurons from Peroxide Toxicity

  1999cites this paper
• Gene Transfer to the Nigrostriatal System by Hybrid Herpes Simplex Virus/Adeno-Associated Virus Amplicon Vectors

  1999cites this paper
• Genetic Analysis of the Role of Protein Kinase C Signaling Pathways in Behaviors by Direct Gene Transfer with HSV-1 Vectors

  1999cites this paper
• Nuclear localization signal peptides enhance cationic liposome-mediated gene therapy.

  1998cites this paper
• High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5

  1998cites this paper
• Defining Responsiveness of Avian Cochlear Neurons to Brain‐Derived Neurotrophic Factor and Nerve Growth Factor by HSV‐1‐Mediated Gene Transfer

  1998cites this paper
• Viral vectors, tools for gene transfer in the nervous system.

  1998cites this paper
• Engineering Herpes Simplex

  1997cites this paper
• Molecular Modification of Neural Networks: Altering Synaptic Function Through the use of Viral Mediated Gene Transfer

  1997cites this paper
• Somatic gene transfer approaches to manipulate neural networks.

  1997cites this paper
• Development of an HSV-based vector for the treatment of Parkinson's disease.

  1997cites this paper
• Targeted Transduction of CNS Neurons with Adenoviral Vectors Carrying Neurotrophic Factor Genes Confers Neuroprotection That Exceeds the Transduced Population

  1997cites this paper
• Neuroprotective signal transduction: relevance to stroke.

  1997cites this paper
• Pharmacology of neurotrophic factors.

  1997cites this paper
• Gene therapeutic strategies for neuroprotection: implications for Parkinson's disease.

  1997cites this paper
• An HSV‐1 Vector Containing the Rat Tyrosine Hydroxylase Promoter Enhances Both Long‐Term and Cell Type‐Specific Expression in the Midbrain

  1997cites this paper
• Use of the herpes amplicon system as a vehicle for somatic gene transfer.

  1997cites this paper
• The neuroprotective effect of the heat shock proteins.

  1997cites this paper
• Expression of the lacZ reporter gene in the rat basal forebrain, hippocampus, and nigrostriatal pathway using a nonreplicating herpes simplex vector.

  1996cites this paper
• Prolonged In Vivo Gene Expression Driven by a Tyrosine Hydroxylase Promoter in a Defective Herpes Simplex Virus Amplicon Vector

  1996influential citation
• Regeneration of the Auditory Nerve: The Role of Neurotrophic Factors

  1996cites this paper
• Expression of the bcl-2 Gene from a Defective HSV-1 Amplicon Vector Protects Pancreatic β-Cells from Apoptosis

  1996cites this paper
• Gene delivery to the central and peripheral nervous systems of mice using HSV1 ICP34.5 deletion mutant vectors.

  1996cites this paper
• Gene transfer to neurons using herpes simplex virus-based vectors.

  1996cites this paper
• Viral vectors for modulating gene expression in neurons.

  1996cites this paper
• Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic beta-cells from apoptosis.

  1996cites this paper
• Neurotrophic factors as pharmacological agents for the treatment of injured auditory neurons.

  1996cites this paper
• The principles of gene therapy for the nervous system.

  1996cites this paper
• Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia.

  1995cites this paper
• Characterization of two populations of ectopic cells isolated from the hearts of NGF transgenic mice.

  1995cites this paper
• Gene therapy in the central nervous system: Direct versus indirect gene delivery

  1995cites this paper
• Differentiation of PC12 cells by infection with an HSV-1 vector expressing nerve growth factor.

  1995cites this paper
• Molecular biology of CNS injury.

  1995cites this paper
• Molecular Strategies in CNS Injury

  1995cites this paper
• The Use of Defective Herpes Simplex Virus Amplicon Vectors to Modify Neural Cells and the Nervous System

  1995cites this paper
• Herpes simplex virus-based vectors

  1995cites this paper
• Long-term expression in sensory neurons in tissue culture from herpes simplex virus type 1 (HSV-1) promoters in an HSV-1-derived vector

  1995cites this paper
• Overexpression of NGF within the heart of transgenic mice causes hyperinnervation, cardiac enlargement, and hyperplasia of ectopic cells.

  1995cites this paper
• Simultaneous detection of amplicon and HSV-1 helper encoded proteins reveals that neurons and astrocytoma cells do express amplicon-borne transgenes in the absence of synthesis of virus immediate early proteins.

  1995cites this paper
• Chapter 7 – Gene delivery using herpes simplex virus type 1 plasmid vectors

  1995cites this paper
• 26 - A Defective Herpes Simplex Virus Vector System for Genetic Intervention in the Adult Brain: Applications to Gene Therapy and Neuronal Physiology

  1994cites this paper